Pangolin Scales Are Keratin: The Science Behind a Billion-Dollar Myth

Every year, tonnes of pangolin scales are smuggled across international borders — the product of a trade that has placed eight species on the IUCN Red List and elevated the pangolin to the unenviable status of world's most trafficked wild mammal. The primary driver of this trade is demand for scales in traditional medicine markets, particularly in Vietnam and China, where they are prescribed for conditions ranging from poor lactation to skin disorders to rheumatism.

The scientific question is straightforward: do pangolin scales have any pharmacological properties that could justify this demand? The answer, after multiple independent lines of chemical and biological research, is equally straightforward. They do not.

What Pangolin Scales Are Made Of

Pangolin scales are derived from skin — specifically, they are modified epidermal structures composed almost entirely of alpha-keratin, the same structural protein that forms human fingernails, toenails, hair, and the outer layer of skin. This is not a contested finding; it has been confirmed by multiple analytical methods including amino acid sequencing, infrared spectroscopy, and comparative proteomics.

The protein composition of pangolin scales is dominated by cysteine-rich keratin chains, cross-linked by disulfide bonds that give the scales their hardness and resistance to mechanical stress. This chemical architecture is typical of mammalian alpha-keratin and is functionally similar to rhino horn, horse hooves, and human hair. There is nothing chemically unique to the pangolin about the keratin polymer itself; the scale's distinctive mechanical properties derive from structural organisation — the arrangement of keratin fibres at the micro-scale — not from any novel chemical component.

What Studies Have Tested

Several research groups have conducted systematic analyses of pangolin scale extracts, motivated precisely by the need to provide evidence-based assessments of the scales' purported therapeutic value. The methodological approaches have varied, but the findings have been consistent.

Amino acid analysis — the basic characterisation of protein composition — reveals a profile typical of structural keratins: high in glycine, serine, alanine, cysteine, and leucine, with the exact proportions varying slightly by species. This profile matches what would be expected from any hard keratin tissue and provides no basis for predicting biological activity beyond that of keratin generally.

Bioactivity screening — testing scale extracts against cell lines, enzymes, or microbial cultures to detect any pharmacological effect — has consistently yielded negative results. No antimicrobial activity has been demonstrated. No anti-inflammatory effect has been confirmed in controlled assays. No lactation-promoting mechanism has been identified. The putative anti-rheumatic effect has no biochemical basis, given that rheumatoid arthritis involves immune dysregulation, and keratin protein extracts have no known interaction with the cytokine cascades that drive the condition.

One frequently cited study attempted to identify bioactive peptides by subjecting scale extracts to enzymatic digestion and then screening the resulting peptide fragments for biological activity. The peptide fragments produced were generic keratin degradation products with no unique activity. The study concluded that there was no scientific basis for the therapeutic claims associated with pangolin scales.

Traditional Medicine Context: How the Belief Arose

The use of pangolin scales in traditional Chinese medicine (TCM) is historically documented. The earliest references appear in classical pharmacopoeia texts — including the Ben Cao Gang Mu (Compendium of Materia Medica), compiled by Li Shizhen in the 16th century — which describe scales of the Chinese pangolin (Manis pentadactyla) under the name Chuan Shan Jia. The text attributes to them the properties of dispersing blood stasis, reducing swelling, and promoting lactation in women who have difficulty nursing.

These attributions reflect the theoretical framework of classical Chinese medicine, not empirical pharmacological testing. Within the TCM system, scale-like structures were conceptually associated with penetrating qualities — the ability to "break through" blockages or stimulate flow — an inference drawn from the scale's physical appearance and the animal's burrowing behaviour, not from any experimental observation of biological effect.

The important distinction is between the historical cultural significance of this belief and its empirical status. Traditional knowledge systems have contributed genuinely pharmacologically active compounds to modern medicine — artemisinin from traditional Chinese malaria treatments is the canonical example. But the value of any traditional remedy claim must ultimately be assessed by whether it withstands pharmacological scrutiny. For pangolin scales, it does not.

The Fingernail Comparison

The most direct way to communicate the pharmacological status of pangolin scales is through comparison with human keratin. Human fingernails are composed of the same alpha-keratin protein family. They have the same amino acid profile. They would produce identical peptide fragments if subjected to the same enzymatic digestion protocols used to test pangolin scales.

If a person were to grind their fingernail clippings into a powder and consume them, they would be consuming a material chemically equivalent to powdered pangolin scale. Digestion would break the keratin into amino acids — cysteine, glycine, serine — that would be absorbed from the gut identically to the same amino acids derived from any dietary protein source. There would be no pharmacological effect because the bioavailability of keratin protein as a systemic therapeutic agent is essentially nil: it is not absorbed intact, it has no receptor targets in the gut or systemically, and it contributes only negligible amino acid nutrition relative to normal dietary protein.

This comparison is not polemical. It is a statement of biochemical fact that has clear implications for policy: a trade that kills tens of thousands of pangolins per year is sustained by a belief in the therapeutic properties of a material that is, in every pharmacologically relevant sense, the same as a human fingernail.

The TCM Establishment's Position

The pharmacological evidence has influenced policy within the traditional medicine establishment itself. In 2020, China's National Pharmacopoeia Commission removed pangolin products from its list of approved traditional medicines in the official pharmacopoeia update, citing conservation concerns and acknowledging the availability of alternative treatments. This was a significant regulatory step, removing the formal state endorsement that had historically provided a degree of legitimacy to the trade within Chinese domestic markets.

The removal from the pharmacopoeia does not immediately eliminate demand — prescribing habits embedded over decades, and supply chains already established, do not respond immediately to regulatory changes. But it removes the formal medicinal legitimacy that had made it difficult for authorities to characterise the trade as purely commercial exploitation of a wildlife product.

Why Demand Persists Despite the Evidence

The persistence of demand in the face of contrary evidence is not unique to pangolin scales — it is characteristic of many traditional remedy markets. Several mechanisms sustain demand independent of pharmacological efficacy:

• Placebo effect: Genuine symptom improvement can occur through expectation alone, particularly for subjective symptoms such as pain or fatigue. A patient who believes in the remedy and experiences improvement attributes that improvement to the remedy.
• Natural history of conditions: Many conditions for which pangolin scales are prescribed — including mastitis and skin inflammations — resolve spontaneously. Resolution coincident with treatment is attributed to the treatment.
• Cultural authority: In communities where traditional medicine has deep cultural roots, the authority of practitioners who prescribe pangolin-derived remedies carries weight that scientific counter-evidence struggles to displace, particularly when that evidence is communicated from outside the cultural context.
• Scarcity premium: As pangolin scales have become scarcer and more expensive with tighter enforcement, they have acquired luxury status. Expensive remedies are culturally coded as powerful remedies in many contexts, making demand partially price-inelastic.
• Supply chain incentives: Traders, intermediaries, and practitioners who derive income from the pangolin scale market have financial incentives to sustain demand narratives regardless of the scientific evidence.

Demand Reduction: What Works

Conservation organisations working on demand reduction have learned that presenting the pharmacological evidence alone is insufficient to change behaviour. More effective strategies combine the scientific evidence with culturally resonant messaging:

Messaging that emphasises the availability of plant-based TCM substitutes — which have been formally endorsed by practitioners and have equivalent traditional indications — has proved more effective than purely conservation-framed messaging. Framing the consumption of a critically endangered wild animal as socially undesirable, rather than primarily ecologically harmful, has shown impact in urban consumer segments. Engagement with respected TCM practitioners to communicate the lack of pharmacological basis, and to encourage substitution, creates authoritative messenger effects that reach communities scientific communications do not.

The fundamental challenge remains: the trade that threatens eight species of pangolin across two continents is fuelled by a demand for a material that is pharmacologically identical to human fingernail clippings. Closing that gap between the evidence and the market is as much a challenge of cultural communication as of science or enforcement.

FAQ